Pancreatic cancer: Patients to be given access to life-extending drugs on NHS

In a landmark decision, the National Institute for Health and Care Excellence (NICE) said it will allow advanced pancreatic cancer patients in England access to the life-extending treatment, Abraxane, on the NHS.  The treatment has not been routinely available to patients in England for almost two years. Hundreds of patients who are eligible for Abraxane […]